XML 40 R29.htm IDEA: XBRL DOCUMENT v3.21.2
Schedule of MSA Fee Expense Classification in Unaudited Condensed Statement of Operations (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Sep. 30, 2021
Sep. 30, 2020
Related Party Transaction [Line Items]                
Cost of Revenue $ 144,273         $ 144,273
Commercial Operations 978,048     335,163     2,688,519 671,636
General & Administrative 3,397,613     470,278     7,731,391 1,260,371
Research & Development 2,189,871     1,216,236     5,814,397 3,616,866
PAVmed Inc. [Member] | Management Services Agreement [Member]                
Related Party Transaction [Line Items]                
Cost of Revenue 39,682 39,682
Commercial Operations 352,055 295,800 323,400 148,200 56,700 43,200 971,255 248,100
General & Administrative 254,575 348,000 269,500 245,100 118,800 118,800 872,075 482,700
Research & Development 223,688 226,200 177,100 176,700 94,500 108,000 626,988 379,200
Total MSA Fee $ 870,000 $ 870,000 $ 770,000 $ 570,000 $ 270,000 $ 270,000 $ 2,510,000 $ 1,110,000